Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Çobanoglu (Ankara, Turkey), E. Kelestemur (Ankara, Turkey), O. Ceylan Dogan (Ankara, Turkey), T. Eminoglu (Ankara, Turkey). Evaluation of Serum Chitotriozidase Activity and C - reactive protein and Albumin Ratio in Cystic Fibrosis and Bronchopulmonary Dysplasia. 2060

Member's Comments

No comment yet.

Related content which might interest you: Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Clinical Correlates of Physical Activity in Idiopathic Pulmonary Fibrosis (IPF) Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Differential Expression of Plasma Metabolites in Patients with Pulmonary Sarcoidosis is Associated with Clinical Behavior Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Does physiotherapy affect Lung Clearance Index in Cystic Fibrosis patients ? Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research Year: 2018 Dynamic Balance, Exercise Capacity and Muscle Oxygenation in Children with Non Cystic Fibrosis Bronchiectasis Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy Year: 2020 Effects of Telerehabilitation on Peripheral Muscle Function in Pediatric Cystic Fibrosis Patients During Covid-19 Pandemic Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients Year: 2021 Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias Year: 2018 Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Nasal Nitric Oxide Sampling In 0-5-year-old Patients With Cystic Fibrosis, Primary Ciliary Dyskinesia and Healthy Controls Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021 Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021 Prognostic Factors in Patients with Idiopathic Pulmonary Fibrosis; Evaluation using Quantitative CT Analysis of Fibrosis and Emphysema Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Treatment of Idiopathic Pulmonary Fibrosis - Executive Summary Source: Guideline 2015 Year: 2015 Nitrofurantoin Induced Pulmonary Fibrosis: A Case Series Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases Year: 2021 Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Development Of A Machine Learning Combination With Deep Learning For Diagnosing Idiopathic Pulmonary Fibrosis In Chronic Interstitial Lung Disease Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Treatment of Idiopathic Pulmonary Fibrosis - Evidence to Decision Frameworks Source: Guideline 2015 Year: 2015 Impact of Anemia On Clinically Stable Adult Non-cystic Fibrosis Bronchiectasis Source: International Congress 2018 – Management of bronchiectasis and large airway diseases Year: 2018 Increased Osteoporosis and Hospitalization in Non-Cystic Fibrosis Bronchiectasis (NCFBr) Adults with Desaturation during 6 Minute Walk Test: a Five-year Study Source: International Congress 2017 – Latest insights into chronic care Year: 2017